⚠️ Research Use Only — Compounds discussed are research chemicals, not FDA-approved for human use. Not medical advice. Full disclaimers →
Also known as: Delta Sleep-Inducing Peptide
DSIP is a sleep peptide research compound (not FDA-approved for human use) studied for improved sleep quality. DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied for improving deep sleep quality and reducing nighttime awakenings in people with chronic insomnia. Research dose: 100–100 mcg 7x/wk. Half-life: 8 minutes. Available from COA-verified vendors with code PEPTIDEX for up to 20% off.
Rankings independent · Research use only
Modulates sleep-wake cycle. Promotes delta-wave (deep) sleep phases. Interacts with GABA, serotonin, and opioid pathways.
COA-verified vendors · Use code PEPTIDEX for up to 20% off
* Prices for research peptide acquisition. Not therapeutic products.
| Vendor | Purity | List Price | With PEPTIDEX | Code | Shop |
|---|---|---|---|---|---|
Amino ClubEditor's Pick | 99%+ | $29.995 mg | $23.99Save 20% | PEPTIDEX | * Research vendor — verify your regional regulations before purchase. Shop |
Bio Longevity LabsTriple-Tested | 99%+ | $55.975 mg | $47.57Save 15% | PEPTIDEX | * Research vendor — verify your regional regulations before purchase. Shop |
| 98%+ | $75.0010 mg | $37.50Save 50% | PEPTIDEX | * Research vendor — verify your regional regulations before purchase. Shop |
Use code PEPTIDEX for 20% off at Amino Club.
* Research vendor — verify your regional regulations before purchase.
Shop at Amino ClubUse code PEPTIDEX for 15% off at Bio Longevity Labs.
* Research vendor — verify your regional regulations before purchase.
Shop at Bio Longevity LabsUse code PEPTIDEX for 50% off at Ascension Peptides.
* Research vendor — verify your regional regulations before purchase.
Shop at Ascension PeptidesModulates sleep-wake cycle. Promotes delta-wave (deep) sleep phases. Interacts with GABA, serotonin, and opioid pathways.
Schneider-Helmert & Schoenenberger: DSIP administered IV to chronic insomniacs decreased nocturnal awakenings, reduced sleep latency, and increased total NREM sleep time.
ModerateDSIP normalizes sleep architecture in middle-aged and elderly chronic insomniacs, with improvements maintained during follow-up week after treatment cessation.
ModerateSchneider-Helmert (Experientia): Longer sleep duration, fewer interruptions, and increased REM sleep documented without daytime sedation or side effects.
ModerateStudy demonstrating that repeated DSIP administration produces cumulative buildup effects, progressively normalizing disturbed sleep patterns.
ModerateTherapeutic peptides, including BPC-157 and TB-500, were found to modulate molecular signaling networks influencing tissue regeneration and inflammation resolution in a 2026 review. The research highlighted their mechanistic potential for orthopaedic applications, noting a current lack of clinical trials.
EmergingA 2025 study demonstrated that a novel domain-specific information preservation framework significantly outperformed existing methods in imputing missing neuroimage data and identifying Alzheimer's disease status. The dual-stage model successfully captured modality-specific details to improve diagnostic accuracy.
EmergingA 2024 preclinical study demonstrated that a DSIP-CBBBP fusion peptide modulated neurotransmitter levels and exhibited greater restorative effects on sleep and neurotransmitter imbalance compared to DSIP alone in an insomnia mouse model.
PreclinicalA 2024 study demonstrated that Raman deuterium stable isotope probing can successfully discriminate between bactericidal and bacteriostatic antibiotic modes of action in Escherichia coli. Researchers found that changes in the C-D band intensity serve as a quantifiable marker for early identification of antimicrobial activity.
PreclinicalA 2024 study demonstrated that an electronic nose device successfully predicted chemical contaminants, including acrylamide and 5-hydroxymethylfurfural, in roasted espresso coffee. Researchers found a strong correlation between the device's electronic signals, sensory defects like a burnt smell, and specific contaminant levels.
PreclinicalA 2023 study demonstrated a novel N-to-C peptide synthesis strategy utilizing catalytic thioacid formation and oxidative bond formation with minimal protecting groups. Researchers found this method effectively suppressed epimerization and successfully synthesized the nonapeptide DSIP, offering a cleaner alternative to traditional synthesis.
PreclinicalLimited modern data. Most studies from the 1980s-90s. Safety profile incompletely defined.
See our evidence grading methodology for how we evaluate and grade peptide safety data.
* Dosing data from published literature — not a human use recommendation.
Very short half-life. Take immediately before sleep. Cycle to avoid tolerance.
Last updated: 2026-01 · Laws change frequently. Verify current status in your jurisdiction.
Week 1
Improved sleep onset and delta-wave sleep depth
Weeks 2–4
More restful sleep; potential pain modulation via opioid pathways
Month 2–3
Circadian rhythm stabilization; stress resilience improvement
Long-term
Effects require cycling; cumulative normalization of sleep architecture
| Side Effect | Incidence | Severity |
|---|---|---|
Headache | ~3% of users | mild |
Morning grogginess (wrong timing) Take 30 min before sleep, not earlier | ~5% of users | mild |
Finding verified, high-purity DSIP requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.
View COA-Verified DSIP✓ Third-party tested·✓ US shipping·✓ COA on every batch
Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
⚠️ Educational only · Not medical advice · For research use only. Information on this page is compiled from peer-reviewed literature and is intended strictly for educational and informational purposes. Peptides discussed may be unapproved research chemicals — consult a licensed healthcare professional before considering any peptide compound. Read our full disclaimer
Affiliate disclosure: PeptiDex may earn commissions from purchases made through vendor links on this page. This does not affect our editorial ranking or vendor recommendations — we exclusively feature vendors that pass independent COA verification. See our methodology · Editorial policy
12stacks • exact dosages • cycle lengths • printable reference
No spam. Unsubscribe anytime.
Independent researcher, not a medical professional
PeptiDex Research is the byline used by the independent researcher who builds and maintains PeptiDex. The site is a one-person research project — there is no editorial board, no medical reviewers, and no clinical staff. Content is produced by reading...
View profile